Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2007
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249014 Labeling and detection of post translationally modified proteins
10/25/2007US20070249013 Collections of Traceable Compounds and Uses Thereof
10/25/2007US20070249011 Method for Screening Fungus-Specific Antimicrobial Agent and Kit Therefor
10/25/2007US20070249006 Immunoassays for malondialdehyde-modified low density lipoprotein (and oxidized low density lipoprotein monoclonal antibodies and the cell lines for them; storage stable standard which may be used as a calibrator and/or control; atherosclerosis
10/25/2007US20070249005 Gastrin hormone immunoassays
10/25/2007US20070249004 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule
10/25/2007US20070249003 Detecting the presence of a level of MRP-8/14 that is differentially associated with appendicitis in a sample of blood, plasma or serum; immunoassay
10/25/2007US20070249002 Diagnosing kidney rejection via identification of organ rejection marker in urine; diagnosis, prediction and monitoring of kidney disorders by detection of cytokines, cytokine-related compounds and chemokines in urine; anti-rejection drugs; immunosuppressants
10/25/2007US20070249001 Multiplex Detection Compositions, Methods, and Kits
10/25/2007US20070249000 Method for diagnosing a person having b-cell pathologies
10/25/2007US20070248999 Method for Determining the Concentration of Vital Epithelial Tumor Cells in a Body Fluid
10/25/2007US20070248998 new bone marrow stromal stem cell (BMSSC) marker; for use in selecting a population of cells enriched in BMSSCs, from bone marrow cells, adipose cells, or peripheral blood
10/25/2007US20070248997 Method of using one-dimensional and multi-dimensional nuclear magnetic resonance to identify compounds that interact with target biomolecules
10/25/2007US20070248996 Modulators of beta-amyloid peptide aggregation comprising D-amino acids
10/25/2007US20070248995 Molecules
10/25/2007US20070248994 Sensor constructs and detection methods
10/25/2007US20070248993 Un-supported Polymeric Film with Embedded Microbeads
10/25/2007US20070248992 Method for the determination of the composition of textile fibers
10/25/2007US20070248991 Base carrier for detecting target substance, element for detecting target substance, method for detecting target substance using the element, and kit for detecting target substance
10/25/2007US20070248990 Method for stabilizing functional groups on a surface of a polymer used as solid support for making microarrays
10/25/2007US20070248989 assaying for aprotinin, alpha-1-microglobulin, alpha-1-acid-glycoprotein, microalbumin, and combinations thereof as early biomarker
10/25/2007US20070248988 Binding molecules and methods of use thereof
10/25/2007US20070248987 Target substance detection material and method and kit for detecting target substance
10/25/2007US20070248986 Systems and methods for predicting an individual's risk of developing rheumatoid arthritis
10/25/2007US20070248985 Functional porous substrates for attaching biomolecules
10/25/2007US20070248984 Methods and compositions for separating cells
10/25/2007US20070248983 Device and Method for Simultaneously Identifying Blood Group Antigens
10/25/2007US20070248982 Automatic threshold setting and baseline determination for real-time PCR
10/25/2007US20070248981 Predicting mortality and detecting severe disease
10/25/2007US20070248975 Methods for monitoring the expression of alternatively spliced genes
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248971 Programming microfluidic devices with molecular information
10/25/2007US20070248964 Method and Device for Detection of Nucleic Acids and/or Polypetides
10/25/2007US20070248963 method for identifying pre-neoplastic and/or neoplastic states in mammals
10/25/2007US20070248957 Encoded solid supports for biological processing and assays using same
10/25/2007US20070248953 Pressure Transduced Chemical Assay and Method
10/25/2007US20070248952 Compositions and methods related to profiling a plurality of cells based on peptide binding
10/25/2007US20070248951 Determination method and determination kit
10/25/2007US20070248950 Supported polydiacetylene 3-D arrays for flourescent or phosphorescent detection
10/25/2007US20070248706 Compositions and Methods for Activating Toll-like Receptor 4
10/25/2007US20070248652 Nutritional Food and Feed, Compostition, Processing and Method of Use
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248612 Isolated Plasma And Method For Hyperimmunisation And Plasma Collection
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248607 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248605 Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248591 Preventive/Therapeutic Drug for Arteriosclerosis
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248580 Identification and Isolation of Multipotent Cells From Non-Osteochondral Mesenchymal Tissue
10/25/2007US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007US20070248545 Use of the receptor GPR86
10/25/2007US20070248544 Mullerian inhibiting substance levels and ovarian response
10/25/2007US20070248539 AgRM2 antigen
10/25/2007US20070248538 Cytotoxicity mediation of cells evidencing surface expression of CD44
10/25/2007US20070248536 conjugate between a polypeptide based on ubiquitin and a functional component wherein the respective polypeptide molecule has a binding property for the specific binding to a ligand which is altered as compared to the wild type polypeptide; diagnostic kit
10/25/2007US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007US20070248246 Electro-optical method and apparatus for evaluating protrusions of fibers from a fabric surface
10/25/2007US20070245812 Semen analysis
10/25/2007US20070245811 Lubricity measurement using mems sensor
10/25/2007US20070245810 Detection Cartridges, Modules, Systems and Methods
10/25/2007US20070245801 Breath alcohol-measuring device with piezo drive
10/25/2007DE112005002212T5 Externe Modifikation von organisch anorganischen Verbundnanoclustern External modification of organic inorganic composite nanoclusters
10/25/2007DE102006019379A1 Proteinsequenzierung Protein sequencing
10/25/2007DE102006019213A1 Testmischung Test mixture
10/25/2007DE102006018926A1 Probentisch für eine Lebensmittelanalysevorrichtung Sample table for food analyzing device
10/25/2007DE102006018749A1 Method for investigating and determining protein containing biomaterial e.g. mites and pollen in regards to symptoms of atopic diseases using pyrogallol-red dye, by applying test sample coated with the dye on a reflecting carrier material
10/25/2007DE102006018332A1 Fractionation of blood or substance that is obtained from its fractionation, useful to test and study blood cell, comprises exposing fractioned substance to a magnetic field that is directed to main flow direction of fractioned substance
10/25/2007CA2681714A1 The ultra filtration system for on-line analyzer
10/25/2007CA2680532A1 Droplet-based pyrosequencing
10/25/2007CA2650129A1 Method of measuring residual cancer and predicting patient survival
10/25/2007CA2649698A1 Whole genome evolution technology applied to improve protein and antibody yields by cells
10/25/2007CA2649462A1 Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages
10/25/2007CA2649250A1 Dopaminergic neuron progenitor cell marker 187a5
10/25/2007CA2649154A1 Method and reagent for the specific identification and quantification of one or more proteins in a sample using inductively coupled plasma-mass spectrometry
10/25/2007CA2649068A1 Method for diagnosing in vitro or ex vivo psychiatric disorders and/or intestinal dysbioses
10/25/2007CA2648588A1 Crac modulators and use of same for drug discovery
10/25/2007CA2648322A1 Disheveled pdz modulators
10/25/2007CA2648263A1 Permuted and nonpermuted luciferase biosensors
10/25/2007CA2648218A1 Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals
10/25/2007CA2647843A1 Detection of proteins from circulating neoplastic cells
10/25/2007CA2647743A1 Detection of steroid receptors on circulating carcinoma cells and treatment
10/25/2007CA2647580A1 Method for measuring human megalin
10/25/2007CA2646586A1 Methods and means for assessing hiv gag/protease inhibitor therapy
10/25/2007CA2646497A1 Detection of circulating endothelial cells
10/25/2007CA2641318A1 Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung
10/25/2007CA2634945A1 Soluble human m-csf receptor and uses thereof
10/25/2007CA2634395A1 Nanoporous substrates for analytical methods
10/25/2007CA2613453A1 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
10/24/2007EP1847833A2 Scintillation proximity assay
10/24/2007EP1847831A1 Method for the determination of the composition of textile fibers
10/24/2007EP1847620A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
10/24/2007EP1847619A2 High throughput assay system
10/24/2007EP1847608A1 Member of the TNF ligand family
10/24/2007EP1847606A2 Mitogenic regulators
1 ... 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 ... 3937